Literature DB >> 18325062

Active surveillance: a safe, low-cost prognostic test for prostate cancer.

Anthony Zietman1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18325062     DOI: 10.1111/j.1464-410X.2008.07553.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  1 in total

1.  [A paradigm shift. Defensive strategies for the treatment of localized prostate cancer in the new S3 guideline].

Authors:  L Weissbach; C Schaefer; A Heidenreich
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.